1000/1000
Hot
Most Recent
Liposomes have been extensively developed and used for various clinical applications such as in pharmaceutical, cosmetic, and dietetic fields, due to its versatility, biocompatibility, and biodegradability, as well as the ability to enhance the therapeutic index of free drugs. However, some challenges remain unsolved, including liposome premature leakage, manufacturing irreproducibility, and limited translation success.
Name | Clinical Approval Year | Liposomal Composition | Drug Encapsulated | Drug Type | Route of Administration | Company | References |
---|---|---|---|---|---|---|---|
Doxil | 1995 | HSPC:Cholesterol:DSPE-PEG2000 | Doxorubicin | Chemotherapeutic | I.V. | Johnson & Johnson, Milpitas, CA, USA | [18][19] |
Abelcet | 1995 | DMPC:DMPG | Amphotericin B | Antifungal | I.V. | Leadiant Biosciences. Inc., Rockville, MD, USA | [20][21] |
DaunoXome | 1996 | DSPC:Cholesterol | Daunorubicin | Chemotherapeutic | I.V. | Galen US, Inc., Souderton, PA, USA | [18][22] |
Amphotec | 1996 | Cholesteryl sulphate:Amphotericin B | Amphotericin B | Antifungal | I.V. | Sequus Pharmaceuticals Inc., Menlo Park, CA, USA | [18] |
Inflexal V | 1997 | 70% Lecithin, 20% Cephalin and 10% Phospholipids | Influenza virus antigen, strain A and B | Vaccine | I.M. | Sun Pharmaceutical Industries Ltd., Princeton, NJ, USA | [18][23] |
Ambisome | 1997 | HSPC:DSPG:Cholesterol:Amphotericin B | Amphotericin B | Antifungal | I.V. | Fujisawa Healthcare, Inc. and Gilead Sciences, Inc., Foster City, CA, USA | [18] |
Myocet | 2000 | EPG:Cholesterol | Doxorubicin | Chemotherapeutic | I.V. | Zeneus Pharma Ltd., Oxford, UK | [18][24] |
Visudyne | 2000 | Verteporfin:DMPC and EPG | Verteporfin | Photosensitizer | I.V. | Novartis International AG, Basel, Switzerland | [18] |
DepoDur | 2004 | DOPC:DPPG:Cholesterol:Tricaprylin and Triolein | Morphine sulfate | Narcotic Analgesic | Epidural | Pacira Pharmaceuticals, Inc., Watford, UK | [18][25] |
Mepact | 2004 | DOPS:POPC | Mifamurtide | Immunomodulator/Antitumor | I.V. | Takeda Pharmaceutical Limited, Tokyo, Japan | [18] |
Exparel | 2011 | DEPC:DPPG:Cholesterol:Tricaprylin | Bupivacaine | Anesthetic | I.V. | Pacira Pharmaceuticals, Inc., Parsippany-Troy Hills, NJ, USA | [18] |
Onivyde | 2015 | DSPC:MPEG-2000:DSPE | Irinotecan | Chemotherapeutic | I.V. | Merrimack Pharmaceuticals, Inc., Cambridge, MA, USA | [18][26] |
Vyxeos | 2017 | DSPC:DSPG:Cholesterol | Daunorubicin + Cytarabine | Antineoplastic | I.V. | Jazz Pharmaceuticals, Inc., Dublin, Ireland | [27] |
Onpattro | 2018 | Cholesterol, DLin-MC3-DMA:DSPC:PEG2000-C-DMG | Patisiran | RNAi agent | I.V. | Alnylam Pharmaceuticals, Cambridge, MA, USA | [28] |
Comirnaty | 2021 | ALC-0315:ALC-0159:cholesterol:DSPC | Nucleoside-modified mRNA encoding the viral spike (S) glycoprotein of SARS-CoV-2 | Vaccine | I.M. | Pfizer-BioNTech, Mainz, Germany | [29] |
Spikevax | 2022 | SM-102:mPEG2000-DMG:Cholesterol:DSPC | Nucleoside-modified mRNA encoding the viral spike (S) glycoprotein of SARS-CoV-2 | Vaccine | I.M. | Moderna, Cambridge, MA, USA | [30] |